We are live on ! Find out more
BDSX icon

Biodesix
BDSX

46 hedge funds and large institutions have $7.06M invested in Biodesix in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

12% more funds holding

Funds holding: 41 → 46 (+5)

0.08% less ownership

Funds ownership: 0.75% → 0.67% (-0.08%)

6% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 16

67% less capital invested

Capital invested by funds: $21.4M → $7.06M (-$14.3M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
46
Holders Change
+5
Holders Change %
+12.2%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
15
Reduced
16
Closed
5
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$67K

Top Buyers

1
Wells Fargo
Wells Fargo
California
+$1.77M
2
ECM
Endurant Capital Management
California
+$427K
3
Millennium Management
Millennium Management
New York
+$295K
4
PPA
Parametric Portfolio Associates
Washington
+$90.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$60.7K

Top Sellers

1
PGM
Parian Global Management
New York
-$2.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$510K
3
Citadel Advisors
Citadel Advisors
Florida
-$104K
4
JP Morgan Chase
JP Morgan Chase
New York
-$101K
5
PP
PDT Partners
New York
-$91K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Birchview Capital
Vermont
$2.12M – – –
BlackRock
2
BlackRock
New York
$962K -$25K -382 -1%
Wells Fargo
3
Wells Fargo
California
$918K +$1.77M +27,098 +7,094%
Vanguard Group
4
Vanguard Group
Pennsylvania
$372K -$510K -7,807 -42%
CC
5
Cannell & Co
New York
$347K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$303K +$60.7K +929 +12%
Millennium Management
7
Millennium Management
New York
$240K +$295K +4,509 +174%
State Street
8
State Street
Massachusetts
$236K +$8.76K +134 +2%
FAM
9
Fred Alger Management
New York
$226K -$2.55K -39 -0.6%
ECM
10
Endurant Capital Management
California
$221K +$427K +6,538 New
Northern Trust
11
Northern Trust
Illinois
$174K -$8.3K -127 -2%
BCM
12
Bridgeway Capital Management
Texas
$144K -$65.4K -1,000 -19%
Two Sigma Investments
13
Two Sigma Investments
New York
$125K +$21.8K +333 +10%
Morgan Stanley
14
Morgan Stanley
New York
$94K -$30.8K -472 -14%
William Blair & Company
15
William Blair & Company
Illinois
$78K +$16.9K +259 +13%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$66K +$15.7K +240 +14%
Charles Schwab
17
Charles Schwab
California
$58K +$8.82K +135 +9%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$50K +$457 +7 +0.5%
PPA
19
Parametric Portfolio Associates
Washington
$47K +$90.3K +1,382 New
CC
20
Chicago Capital
Illinois
$39K -$11.8K -180 -13%
N
21
Nuveen
North Carolina
$39K – – –
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$39K +$3.2K +49 +4%
JP Morgan Chase
23
JP Morgan Chase
New York
$31K -$101K -1,548 -63%
Citadel Advisors
24
Citadel Advisors
Florida
$30K -$104K -1,585 -64%
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$18K -$65 -1 -0.2%
1
2

BDSX Hedge Fund Activity: Q1 2022 in Review

46 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2022, worth a combined $7.06M — down 67% from $21.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BDSX positions and 5 closed out — a net gain of 5 holders — while 15 added to existing stakes and 16 trimmed.

The largest buyer was Wells Fargo, adding an estimated $1.77M. The largest seller was Parian Global Management, exiting entirely with an estimated $2.1M sold.

  • 46 institutional investors held Biodesix (BDSX) as of Q1 2022, up from 41 in Q4 2021.
  • Funds reported $7.06M of Biodesix stock for Q1 2022, down 67% quarter-over-quarter.
  • 10 funds opened new Biodesix positions in Q1 2022 and 5 closed out, a net change of +5 holders.
  • The largest Biodesix buyer in Q1 2022 was Wells Fargo, an estimated $1.77M added.
  • The largest Biodesix seller in Q1 2022 was Parian Global Management, an estimated $2.1M sold.

Based on aggregated 13F filings for Q1 2022.